Moberg Pharma AB (publ)

OM:MOB Stock Report

Market Cap: SEK 1.6b

Moberg Pharma Management

Management criteria checks 2/4

Moberg Pharma's CEO is Anna Ljung, appointed in May 2019, has a tenure of 5.25 years. total yearly compensation is SEK3.51M, comprised of 56.6% salary and 43.4% bonuses, including company stock and options. directly owns 0.016% of the company’s shares, worth SEK255.12K. The average tenure of the management team and the board of directors is 4.8 years and 1.8 years respectively.

Key information

Anna Ljung

Chief executive officer

SEK 3.5m

Total compensation

CEO salary percentage56.6%
CEO tenure5.3yrs
CEO ownership0.02%
Management average tenure4.8yrs
Board average tenure1.8yrs

Recent management updates

Moberg Pharma AB (publ)'s (STO:MOB) CEO Will Probably Find It Hard To See A Huge Raise This Year

May 08
Moberg Pharma AB (publ)'s (STO:MOB) CEO Will Probably Find It Hard To See A Huge Raise This Year

Recent updates

Moberg Pharma AB (publ)'s (STO:MOB) CEO Will Probably Find It Hard To See A Huge Raise This Year

May 08
Moberg Pharma AB (publ)'s (STO:MOB) CEO Will Probably Find It Hard To See A Huge Raise This Year

Moberg Pharma (STO:MOB) Will Have To Spend Its Cash Wisely

Nov 16
Moberg Pharma (STO:MOB) Will Have To Spend Its Cash Wisely

Will Moberg Pharma (STO:MOB) Spend Its Cash Wisely?

Jan 17
Will Moberg Pharma (STO:MOB) Spend Its Cash Wisely?

Read This Before Selling Moberg Pharma AB (publ) (STO:MOB) Shares

Dec 03
Read This Before Selling Moberg Pharma AB (publ) (STO:MOB) Shares

CEO Compensation Analysis

How has Anna Ljung's remuneration changed compared to Moberg Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-SEK 23m

Dec 31 2023SEK 4mSEK 2m

-SEK 21m

Sep 30 2023n/an/a

-SEK 18m

Jun 30 2023n/an/a

-SEK 16m

Mar 31 2023n/an/a

-SEK 16m

Dec 31 2022SEK 3mSEK 2m

-SEK 16m

Sep 30 2022n/an/a

-SEK 17m

Jun 30 2022n/an/a

-SEK 16m

Mar 31 2022n/an/a

-SEK 16m

Dec 31 2021SEK 2mSEK 1m

-SEK 16m

Sep 30 2021n/an/a

SEK 8m

Jun 30 2021n/an/a

SEK 7m

Mar 31 2021n/an/a

SEK 5m

Dec 31 2020SEK 3mSEK 2m

SEK 7m

Jun 30 2020n/an/a

SEK 20m

Jun 30 2019SEK 476kSEK 151k

-SEK 8m

Compensation vs Market: Anna's total compensation ($USD327.13K) is below average for companies of similar size in the Swedish market ($USD473.91K).

Compensation vs Earnings: Anna's compensation has increased whilst the company is unprofitable.

CEO

Anna Ljung (44 yo)

5.3yrs

Tenure

SEK 3,511,000

Compensation

Ms. Anna Ljung, M.Sc. Econ., BA serves as Chairperson of Biosergen AB since June 14, 2024. She served as Chairman of The Board at OncoZenge AB (publ) until August 2023. She joined company since 2020.Ms. L...

Leadership Team

NamePositionTenureCompensationOwnership
Anna Ljung
Chief Executive Officer5.3yrsSEK 3.51m0.016%
SEK 255.1k
Marie Moberg
Co-Founder18.4yrsSEK 193.70kno data
Mark Beveridge
Vice President of Finance4.8yrsno data0.033%
SEK 537.2k
Christina Erixon
Head of Pharmaceutical Development & Operationsless than a yearno datano data
Gunilla Wengström
Senior Director of Sales & Marketing5.6yrsno datano data
Anders Broijersen
Chief Medical Officer1.8yrsno data0.000020%
SEK 322.9
Robert Ehrl
Head of Supplyless than a yearno datano data

4.8yrs

Average Tenure

54yo

Average Age

Experienced Management: MOB's management team is considered experienced (4.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Howard Maibach
Member of Scientific Advisory Boardno datano datano data
Jonas Ekblom
Directorless than a yearno datano data
Hakan Wallin
Independent Director1.3yrsSEK 99.00kno data
Nikolaj Sorensen
Independent Director3.3yrsSEK 170.00k0.17%
SEK 2.8m
Jan Faergemann
Member of Scientific Advisory Boardno datano datano data
Lennart Emtestam
Member of Scientific Advisory Boardno datano datano data
Johan Heilborn
Member of Scientific Advisory Boardno datano datano data
Bernt Lindelöf
Member of Scientific Advisory Boardno datano datano data
Kerstin Strinnholm
Independent Chairman of the Board2.3yrsSEK 360.00k0.19%
SEK 3.1m

1.8yrs

Average Tenure

60.5yo

Average Age

Experienced Board: MOB's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.